Your browser doesn't support javascript.
loading
Effects of calorie-restricted diet on health state and intestinal flora in Hashimoto's thyroiditis patients: Study protocol for a randomized controlled trial.
Huang, Qingling; Pan, Kaixin; Zhang, Yuxuan; Li, Songtao; Li, Jiaomei.
  • Huang Q; School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
  • Pan K; School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
  • Zhang Y; School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
  • Li S; School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
  • Li J; School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China. Email: jiaomeili90@163.com.
Asia Pac J Clin Nutr ; 33(3): 397-404, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38965727
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Hashimoto's thyroiditis (HT) is an autoimmune disease, characterized by abnormal elevation in thyroid peroxidase antibody and/or thyroglobulin antibody. In recent decades, HT disease has become more and more widespread. Patients always report multiple symptoms, even though their thyroid hormone levels are kept in normal ranges. However, no treatment exists to effectively reduce the levels of thyroid antibodies. Our study aims to determine whether calorie-restricted diet is helpful in improving health of HT patients. METHODS AND STUDY

DESIGN:

This is a 3-month randomized controlled trial. HT patients will be randomized into a calorie-restricted (CR) group or a calorie-unrestricted control group. All the participants will be instructed to consume a diet that includes a combination of 45-55% calories from carbohydrates, 20-30% from fats, and 15-25% from proteins, according to current Chinese Dietary Guidelines. Participants in CR group need to limit their calories intake equal to their basal energy expenditure, which means that their daily caloric intake will be limited by about 20-30%.

RESULTS:

The study population is planned to be 66 HT patients aged 18 to 65 years. The primary outcome is change of thyroid antibody levels from baseline. Secondary outcomes include the changes of non-hypothyroid symptoms scores, thyroid function indexes, morphology of thyroid, T lymphocyte subpopulations, inflammatory biomarkers and lipids from baseline to 12 weeks.

CONCLUSIONS:

This trial will have implications for nutrition treatment policy in regard to thyroid antibodies control, immune dysfunction and related non-hypothyroid symptoms improvement among HT patients.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Restricción Calórica / Enfermedad de Hashimoto / Microbioma Gastrointestinal Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Restricción Calórica / Enfermedad de Hashimoto / Microbioma Gastrointestinal Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article